Comex Reports Swaziland 30 - pharmaceutical products 3002 - human or animal blood

Deploy a report





Chart - Swaziland - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Swaziland - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Swaziland - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
Belgium 1.305.979 3.436.254 2.166.920 1.223.025 2.133.370
South Africa 930.807 1.740.705 2.028.003 1.785.456 1.587.426
Netherlands 547.463 400.042 81.422 508.197 662.081
Germany 966.885 334.448 207.137
United States 20.984 379.185 679.184 13.065
Italy 106.697 56.280
Sweden 68.987 05 37
South Korea 54.000 5.000 1.000
France 23.296 5.315
Bulgaria 4.839 4.588 7.165 1.243
Others 3.370 19.313 351 2.497
Total 3,038,287 6,064,918 5,927,001 3,864,956 4,606,857

Chart - Swaziland - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Swaziland - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Swaziland - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
 03 - 2025 04 - 2025 05 - 2025 06 - 2025 07 - 2025
South Africa 174.776 104.725 87.595 157.877 128.038
United States 14.040
Total 174,776 118,765 87,595 157,877 128,038

Chart - Swaziland - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Swaziland - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Swaziland - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Import Countries
 2020 2021 2022 2023 2024
Taiwan 562.000 436.000 393.000 150.000
Ireland 223.138 270.154 37
Israel 199.000
Netherlands 03 114.137
South Korea 3.000
Brazil 2.144
Denmark 748 412
Belgium 663
Total 562,000 664,282 663,820 349,786 114,548

Chart - Swaziland - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Swaziland - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Swaziland - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Import Countries
 03 - 2025 04 - 2025
Denmark 45 73
Total 45 73

Chart - Swaziland - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Swaziland - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Swaziland - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
Importaciones
Belgium 1.305.979 3.436.254 2.166.920 1.223.025 2.133.370
South Africa 930.807 1.740.705 2.028.003 1.785.456 1.587.426
Netherlands 547.463 400.042 81.422 508.197 662.081
Germany 966.885 334.448 207.137
United States 20.984 379.185 679.184 13.065
Italy 106.697 56.280
Sweden 68.987 05 37
South Korea 54.000 5.000 1.000
France 23.296 5.315
Bulgaria 4.839 4.588 7.165 1.243
Others 3.370 19.313 351 2.497
Total 3,038,287 6,064,918 5,927,001 3,864,956 4,606,857

Date
Import Countries
 2020 2021 2022 2023 2024
Exportaciones
Taiwan 562.000 436.000 393.000 150.000
Ireland 223.138 270.154 37
Israel 199.000
Netherlands 03 114.137
South Korea 3.000
Brazil 2.144
Denmark 748 412
Belgium 663
Total 562,000 664,282 663,820 349,786 114,548

Chart - Swaziland - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Swaziland - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Swaziland - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
 03 - 2025 04 - 2025 05 - 2025 06 - 2025 07 - 2025
Importaciones
South Africa 174.776 104.725 87.595 157.877 128.038
United States 14.040
Total 174,776 118,765 87,595 157,877 128,038

Date
Import Countries
 03 - 2025 04 - 2025
Exportaciones
Denmark 45 73
Total 45 73